chr15-98649640-C-T
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 1P and 2B. PP2BP4_Moderate
The NM_000875.5(IGF1R):c.59C>T(p.Ser20Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000255 in 1,609,984 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000875.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IGF1R | NM_000875.5 | c.59C>T | p.Ser20Phe | missense_variant | 1/21 | ENST00000650285.1 | NP_000866.1 | |
IRAIN | NR_126453.2 | n.1148G>A | non_coding_transcript_exon_variant | 1/1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IGF1R | ENST00000650285.1 | c.59C>T | p.Ser20Phe | missense_variant | 1/21 | NM_000875.5 | ENSP00000497069 | P4 | ||
IGF1R | ENST00000559925.5 | n.59C>T | non_coding_transcript_exon_variant | 1/10 | 1 | |||||
IGF1R | ENST00000649865.1 | c.59C>T | p.Ser20Phe | missense_variant | 1/21 | ENSP00000496919 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000396 AC: 6AN: 151378Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000324 AC: 8AN: 247164Hom.: 0 AF XY: 0.0000373 AC XY: 5AN XY: 134088
GnomAD4 exome AF: 0.0000240 AC: 35AN: 1458606Hom.: 0 Cov.: 31 AF XY: 0.0000234 AC XY: 17AN XY: 725626
GnomAD4 genome AF: 0.0000396 AC: 6AN: 151378Hom.: 0 Cov.: 33 AF XY: 0.0000406 AC XY: 3AN XY: 73830
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 07, 2023 | The c.59C>T (p.S20F) alteration is located in exon 1 (coding exon 1) of the IGF1R gene. This alteration results from a C to T substitution at nucleotide position 59, causing the serine (S) at amino acid position 20 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 12, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The phenylalanine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. This variant has not been reported in the literature in individuals affected with IGF1R-related conditions. This variant is present in population databases (rs367826969, gnomAD 0.007%). This sequence change replaces serine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 20 of the IGF1R protein (p.Ser20Phe). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at